Pharmacies get a second postponement of DSCSA requirement, now due March 1, 2016
FDA fiddles with legislated deadline schedule
Pharmacies and some health systems are getting another breather from FDA: the requirement to have product tracing information (at the lot level) on hand was supposed to go into effect on July 1, which was pushed back to November 1, and now is being pushed to March 1, 2016.
Many of the details of the Drug Supply Chain Security Act (DSCSA) were written into the law itself, but FDA has some degree of “enforcement discretion” even with mandated deadlines. Manufacturers were to begin collecting and then passing tracing data on Jan 1 of this year, but FDA pushed that off to May 1. Getting two postponements certainly indicates a less-than-enthusiastic response to the law, but as there are subsequent deadlines for other traceability criteria hitting in 2017 and beyond, the pharmacy sector will be compelled to get up to speed, eventually. The postponement is also an acknowledgement that FDA simply can’t shut down dispensing activity because of noncompliance; the effects on public health would be severe.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
